Terlipressin in Upper GI Bleeding: Specific Role in Variceal Hemorrhage
Critical Indication: Variceal Bleeding Only
- The American College of Gastroenterology recommends terlipressin for bleeding esophageal or gastric varices secondary to portal hypertension in cirrhotic patients, as it has no role in non-variceal upper GI bleeding, with a high level of evidence 2
- Terlipressin works by causing splanchnic vasoconstriction, reducing portal venous inflow and lowering portal pressure, with a moderate level of evidence 1, 3
Dosing Algorithm
- The European Association for the Study of the Liver recommends an initial dose of 2 mg IV bolus every 4 hours until bleeding is controlled, with a high level of evidence 1, 2
- The maintenance phase involves reducing the dose to 1 mg IV every 4 hours, with a moderate level of evidence 1, 2
Mandatory Combination Therapy—Never Monotherapy
- The American Association for the Study of Liver Diseases recommends combining terlipressin with endoscopic band ligation within 12 hours of presentation, prophylactic antibiotics, and restrictive transfusion strategy, with a high level of evidence 1, 2
- Combination therapy achieves 77% five-day hemostasis versus only 58% with endoscopy alone, with a moderate level of evidence 2
Proven Mortality Benefit
- Terlipressin is the only vasoactive drug proven to reduce bleeding-related mortality by 34% compared to placebo, with a high level of evidence 1, 2
- The mortality benefit distinguishes terlipressin from somatostatin and octreotide, which have not consistently demonstrated mortality reduction despite similar hemostasis rates, with a moderate level of evidence 1
Absolute Contraindications
- The American College of Cardiology recommends avoiding terlipressin in patients with active coronary, peripheral, or mesenteric ischemia, with a high level of evidence 1, 3
- The European Society of Gastrointestinal Endoscopy recommends avoiding terlipressin in patients with hypoxia or worsening respiratory symptoms, with a moderate level of evidence 1, 2, 3